PMID: 18717179Aug 23, 2008Paper

Clinical approach and pathological cascabe of dementia

Rinshō shinkeigaku = Clinical neurology
Mikio Shoji

Abstract

The number of patients with dementia is explosively increasing in major industrialized nations and Asian countries. It is estimated about 2,430,000 patients in the world, 4,000,000 patients in United States and more than 2,000,000 patients in Japan. The number of patients suffered from dementia is predicted to be 4,000,000 patients and occupy and 11% of Japanese population in 2040. Therapy for cure of dementia is still investigated. For this reason, dementia is the most important urgent and crucial concern in the national health and welfare. The major cause of dementia is Alzheimer disease. In this review, clinical symptom and natural course of Alzheimer disease, newly standardized criteria and neuropsychiatric butteries for Alzheimer disease are summarized. Possibility therapy to cure Alzheimer disease targeting Abeta oligomer and advances in research of biomarkers and amyloid imaging are also commented.

References

Nov 1, 1975·Journal of Psychiatric Research·M F FolsteinP R McHugh
May 30, 1998·Proceedings of the National Academy of Sciences of the United States of America·M P LambertW L Klein
Oct 16, 1999·Archives of Neurology·J K JohnsonC W Cotman
Apr 18, 2002·Journal of the Neurological Sciences·Hiroyasu AkatsuKenji Kosaka
Apr 16, 2004·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Takeshi KawarabayashiSteven G Younkin
Dec 20, 2005·Lancet·Cleusa P FerriUNKNOWN Alzheimer's Disease International
Feb 16, 2006·Neurology·Paul McMonagleAndrew Kertesz
Mar 17, 2006·Nature·Sylvain LesnéKaren H Ashe
Jul 21, 2006·Brain : a Journal of Neurology·Henry EnglerAgneta Nordberg
Jul 22, 2006·Lancet Neurology·Marieke van OijenMonique M B Breteler
Jan 16, 2007·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·G WaldemarUNKNOWN EFNS
May 15, 2007·Neurobiology of Aging·Anton ForsbergAgneta Nordberg
May 16, 2007·Neurology·C C RoweV L Villemagne
Jun 21, 2007·Acta Neuropathologica·Nigel J CairnsUNKNOWN Consortium for Frontotemporal Lobar Degeneration
Sep 28, 2007·Brain : a Journal of Neurology·S AlladiJ R Hodges

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Related Papers

Zhongguo shi yan xue ye xue za zhi
Xiao-Meng NieJian-Min Wang
The Journal of Contemporary Dental Practice
F Varon, L Mack-Shipman
Current Drug Targets. Immune, Endocrine and Metabolic Disorders
O RigatoR Salomao
© 2022 Meta ULC. All rights reserved